CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling

Platt, Randall J.; Chen, Sidi; Zhou, Yang; Yim, Michael J.; Swiech, Lukasz; Kempton, Hannah R.; Dahlman, James E.; Parnas, Oren; Eisenhaure, Thomas M.; Jovanovic, Marko; Graham, Daniel B.; Jhunjhunwala, Siddharth; Xavier, Ramnik J.; Langer, Robert; Anderson, Daniel G.; Hacohen, Nir; Regev, Aviv; Feng, Guoping; Sharp, Phillip A.; Zhang, Feng

doi:10.1016/j.cell.2014.09.014

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling

Published Date:

Sep 25 2014

Publisher's site:

http://dx.doi.org/10.1016/j.cell.2014.09.014 New Site Icon

Source:

Cell. 2014; 159(2):440-455.

[PDF - 3.28 MB]

Details:

Personal Authors:

Platt, Randall J. ; Chen, Sidi ; Zhou, Yang ; Yim, Michael J. ; Swiech, Lukasz ; ... More ▼

Keywords:

[+]

Pubmed ID:

25263330

Pubmed Central ID:

PMC4265475

Description:

CRISPR-Cas9 is a versatile genome editing technology for studying the functions of genetic elements. To broadly enable the application of Cas9 in vivo, we established a Cre-dependent Cas9 knockin mouse. We demonstrated in vivo as well as ex vivo genome editing using adeno-associated virus (AAV)-, lentivirus-, or particle-mediated delivery of guide RNA in neurons, immune cells, and endothelial cells. Using these mice, we simultaneously modeled the dynamics of KRAS, p53, and LKB1, the top three significantly mutated genes in lung adenocarcinoma. Delivery of a single AAV vector in the lung generated loss-of-function mutations in p53 and Lkb1, as well as homology-directed repair-mediated Kras(G12D) mutations, leading to macroscopic tumors of adenocarcinoma pathology. Together, these results suggest that Cas9 mice empower a wide range of biological and disease modeling applications.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

268201000045C/PHS HHS/United States
DK43351/DK/NIDDK NIH HHS/United States
DP1 MH100706/MH/NIMH NIH HHS/United States
DP1-MH100706/DP/NCCDPHP CDC HHS/United States
EB000244/EB/NIBIB NIH HHS/United States
P30 CA014051/CA/NCI NIH HHS/United States
P30 DK043351/DK/NIDDK NIH HHS/United States
P30-CA14051/CA/NCI NIH HHS/United States
P50 HG006193/HG/NHGRI NIH HHS/United States
P50 HG006193/HG/NHGRI NIH HHS/United States
R01 DK097768/DK/NIDDK NIH HHS/United States
R01-CA133404/CA/NCI NIH HHS/United States
R01-NS 07312401/NS/NINDS NIH HHS/United States
U54 CA151884/CA/NCI NIH HHS/United States
U54CA151884/CA/NCI NIH HHS/United States
Howard Hughes Medical Institute/United States

Supporting Files:

nihms-631163-f0001.gif	image/gif
nihms-631163-f0001.jpg	image/jpeg
nihms-631163-f0002.gif	image/gif
nihms-631163-f0002.jpg	image/jpeg
nihms-631163-f0003.gif	image/gif
nihms-631163-f0003.jpg	image/jpeg
nihms-631163-f0004.gif	image/gif
nihms-631163-f0004.jpg	image/jpeg
nihms-631163-f0005.gif	image/gif
nihms-631163-f0005.jpg	image/jpeg
nihms-631163-f0006.gif	image/gif
nihms-631163-f0006.jpg	image/jpeg
nihms-631163-f0007.gif	image/gif
nihms-631163-f0007.jpg	image/jpeg
nihms-631163.nxml	application/octet-stream
NIHMS631163-supplement-1.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
NIHMS631163-supplement-10.pdf	application/pdf
NIHMS631163-supplement-11.pdf	application/pdf
NIHMS631163-supplement-12.pdf	application/pdf
NIHMS631163-supplement-2.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
NIHMS631163-supplement-3.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
NIHMS631163-supplement-4.xlsx	application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
NIHMS631163-supplement-5.avi	application/x-troff-msvideo
NIHMS631163-supplement-6.pdf	application/pdf
NIHMS631163-supplement-7.pdf	application/pdf
NIHMS631163-supplement-8.pdf	application/pdf
NIHMS631163-supplement-9.pdf	application/pdf

No Related Documents.

You May Also Like:

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

Personal Author:

Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Trevino, Alexandro; Scott, David A.; Inoue, Azusa; Matoba, Shogo; Zhang, Yi; Zhang, Feng;

Published:

Aug 29 2013

Source:

Cell. 2013; 154(6):1380-1389.

Description:

Targeted genome editing technologies have enabled a broad range of research and medical applications. The Cas9 nuclease from the microbial CRISPR-Cas system is targeted to specific genomic loci by a 20 nt guide sequence, which can tolerate certain mi...

File Type:

[PDF - 1.36 MB]
CRISPR-Cas systems for genome editing, regulation and targeting

Personal Author:

Sander, Jeffry D.; Joung, J. Keith;

Published:

Mar 02 2014

Source:

Nat Biotechnol. 32(4):347-355.

Description:

Targeted genome editing using engineered nucleases has rapidly gone from being a niche technology to a mainstream method used by many biological researchers. This widespread adoption has been largely fueled by the emergence of the clustered, regularl...

File Type:

[PDF - 1.13 MB]
Development and Applications of CRISPR-Cas9 for Genome Engineering

Personal Author:

Hsu, Patrick D.; Lander, Eric S.; Zhang, Feng;

Published:

Jun 5 2014

Source:

Cell. 2014; 157(6):1262-1278.

Description:

Recent advances in genome engineering technologies based on the CRISPR-associated RNA-guided endonuclease Cas9 are enabling the systematic interrogation of mammalian genome function. Analogous to the search function in modern word processors, Cas9 ca...

File Type:

[PDF - 867.35 KB]
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing

Personal Author:

Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Thapar, Vishal; Reyon, Deepak; Goodwin, Mathew J.; Aryee, Martin J.; Joung, J. Keith;

Published:

Apr 25 2014

Source:

Nat Biotechnol. 32(6):569-576.

Description:

Monomeric CRISPR-Cas9 nucleases are widely used for targeted genome editing but can induce unwanted off-target mutations with high frequencies. Here we describe dimeric RNA-guided FokI nucleases (RFNs) that can recognize extended sequences and edit e...

File Type:

[PDF - 1.62 MB]
Genome engineering using the CRISPR-Cas9 system

Personal Author:

Ran, F Ann; Hsu, Patrick D; Wright, Jason; Agarwala, Vineeta; Scott, David A; Zhang, Feng;

Published:

Oct 24 2013

Source:

Nat Protoc. 2013; 8(11):2281-2308.

Description:

Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facili...

File Type:

[PDF - 1.94 MB]